Affymetrix (NASDAQ:AFFX) today announced that Founder and Chairman, Stephen Fodor, Ph.D., will retire from the company's Board of Directors effective January 30, 2015. He has served on the Board since the Company's inception, and has been Chairman since 1999. The Board of Directors elected Jami Nachtsheim as Chairwoman of the Company's Board of Directors, succeeding Dr. Fodor. Ms. Nachtsheim has served as a director of the Company since 2010 and the Company's lead independent director since 2013.

Dr. Fodor founded the company in 1992, initially serving as its Scientific Director. He was named the company's President in 1993 and CEO from 1997 to 2008. Since 2011, Frank Witney, Ph.D., has served as the company's President and CEO and an Affymetrix Board Director.

"Frank and the management team have done a terrific job returning excitement and growth to the company, and I am confident they will continue to be successful," said Dr. Fodor. "This is the right time to pursue my external activities. My interest, involvement and enthusiasm for the life sciences industry will continue."

Frank Witney, President and CEO, said, "Steve's insights, leadership and vision have been core to the culture of Affymetrix. Much of what we know about modern biology has been learned using Affymetrix products, as evidenced by over 94,000 publications referencing our technology. Steve built the foundation of scientific innovation at the company, which we intend to carry forward. We wish Steve all the best in his future endeavors."

About Affymetrix

Affymetrix technologies enable multiplex and simultaneous analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of bench-top research into clinical and routine use for human health and wellness. The Company provides leadership and support, partnering with customers in pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and non-profit research institutes in their quest to use biology for a better world. More than 2,300 microarray systems have been shipped around the world and more than 94,500 peer-reviewed papers have been published citing Affymetrix technologies. Affymetrix is headquartered in Santa Clara, California, and has manufacturing facilities in Cleveland, Ohio, San Diego, Vienna, and Singapore. The Company has about 1,100 employees worldwide and maintains sales and distribution operations across Europe, Asia, and Latin America. For more information about Affymetrix, please visit www.affymetrix.com.

Copyright Business Wire 2010